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S.A. Jensen,1,2 L.J. Vatten,1 T.I.L. Nilsen,1 P.R. Romundstad1 and H.O. Myhre2*Departments of 1Community Medicine and General Practice, and 2Surgery, University Medical Center,
Norwegian University of Science and Technology, N-7489 Trondheim, NorwayPurpose. To study serum lipids, body mass index (BMI), and body shape in relation to intermittent claudication (IC) in
19,748 men and women 40–69 years of age.
Method. All residents (1995–1997) in Nord-Trøndelag County, Norway, were invited to attend the cross sectional study
and received a Norwegian translation of the WHO/Rose questionnaire on intermittent claudication and the Edinburgh
claudication questionnaire. Blood lipids and anthropometric data were measured at a consecutive examination. Odds ratios
(OR) were estimated for associations with IC by multiple regression analysis.
Results. The ratio of total cholesterol to HDL cholesterol (TC/HDL cholesterol) (P trendmenZ.023; P trendwomen!.001)
and triglycerides (P trendmenZ.029; P trendwomenZ.002) were positively associated with the prevalence of IC. HDL
cholesterol was negatively (P trendmenZ.131; P trendwomen!.001) associated, whereas BMI (P trendwomenZ.032), waist
circumference (P trendwomenZ.021), and hip circumference (P trendwomenZ.020) were positively associated with IC in
women, but not in men. Adjustment for smoking, diabetes, and systolic or diastolic blood pressure did not change the results.
Conclusion. TC/HDL cholesterol and triglycerides were positively, and HDL cholesterol negatively associated with IC in
both genders. In women, but not in men, BMI, waist and hip circumference were positively associated with IC.Keywords: Serum lipids; Anthropometric factors; Intermittent claudication.Introduction
Lower limb arterial disease is common in the
population, but for most patients the condition runs
a benign course and will only require medical or
surgical intervention in about one third of the
patients.1–4 For patients with intermittent claudication
(IC), 5 and 10 year mortality are about 30 and 50%
higher, respectively, than the general population.4,5 In
order to improve the survival of patients with
peripheral vascular disease co-ordinated modification
of identifiable risk factors is of major importance. Such
measures include increased physical activity, smoking
cessation, and optimal treatment of hypertension,
dyslipidemia, and diabetes.6,7
Most population studies investigating the epide-
miology of intermittent claudication (IC) were carried
out 20–30 years ago.8–10 The aim of this study was to
examine the relation between serum concentrations of
lipids, body mass, body shape, and the prevalence ofing author. Prof Hans O. Myhre, MD, PhD, Department
orwegian University of Science and Technology, N-7006
orway.
: hans.myhre@medisin.ntnu.no
0582 + 06 $35.00/0 q 2005 Elsevier Ltd. All rights reserIC in an unselected population of nearly 20,000
individuals between 40 and 69 years of age.2Patients and MethodsThe study population
Between 1995 and 1997 all residents 20 years or older
in Nord-Trøndelag County, Norway, were invited to
participate in a health study (HUNT 2).11 In total,
71.2% (66,140) attended and responded to a brief
questionnaire enclosed with the invitation. The study
also included a physical examination, with measure-
ments of height, weight, waist and hip circumference,
brachial blood pressure, and a sample of venous blood
was collected. At the examination, participants 20–69
years of age received another questionnaire including
questions specifically aimed at identifying individuals
with IC. This second questionnaire was to be filled in
at home and returned in a pre-stamped envelope.
Together, answers to the questions in the first and
second questionnaire provided information on aEur J Vasc Endovasc Surg 30, 582–587 (2005)
doi:10.1016/j.ejvs.2005.06.008, available online at http://www.sciencedirect.com onved.
Serum Lipids, Anthropometric Factors, Claudication 583variety of health related issues. Since, IC is very rare at
a young age, we restricted the analysis to participants
40–69 years of age, yielding a study population of 9405
men and 10,343 women.Diagnosing intermittent claudication—validation of the
questions
Twelve questions were constructed to identify indi-
viduals with intermittent claudication and included
Norwegian translations of the questions used in the
WHO/Rose questionnaire on intermittent claudica-
tion and the Edinburgh claudication questionnaire.
Different combinations of the questions were validated
in 333 randomly selected participants using ankle
brachial pressure index !0.9 as the gold standard of
arterial occlusive disease (symptomatic and asympto-
matic subjects). Four simple questions eligible for self-
administration had test properties similar to the
WHO/Rose questionnaire and the Edinburgh claudi-
cation questionnaire.12–14 IC subjects should have pain
(1) in one or both legs during walking; (2) located to
the calf; (3) that disappears after a period of rest; and
(4) which is absent at rest. These questions had a
specificity of 98.0% and a positive predictive value of
45.5%.15,16Serum lipids and anthropometric factors
Total serum cholesterol concentrations were measured
by the Liebermann–Buchard method, and triglycer-
ides by a fluorimetric method.17 HDL cholesterol
concentrations were determined in frozen sera with a
heparin-manganese method.17 The ratio of total
cholesterol to HDL cholesterol was finally calculated
and this ratio will be referred to as TC/HDL
cholesterol.18 Each variable (total cholesterol, HDL
cholesterol, triglycerides, and TC/HDL cholesterol)
was categorized into three approximately equal
groups (tertiles).
Recordings of height (in cm), weight (in kg), and
waist and hip circumference (in cm) were standar-
dized and performed by trained personnel. Body mass
index (BMI) was computed as weight (in kg) divided
by the squared value of height (in m), and body shape
was calculated as waist circumference (in cm) divided
by hip circumference (in cm). All variables were
categorized into tertiles for the statistical analyses.
The presence of diabetes was ascertained by one
simple question in the questionnaire and used as a
dichotomized variable in the regression model. In
addition, non-fasting blood glucose levels (mmol/L)
and HbA1c levels (mg%) were measured in seraobtained at the examination. We used these measures,
treated as ordinal variables, in the multivariate
analyses.
Individuals who had never smoked cigarettes daily
were considered non-smokers, and those who
reported previous or current daily smoking were
classified as former and current smokers, respectively.
Both current and former smokers were asked to report
how many cigarettes they currently usually smoked,
or previously used to smoke. A pack-year was defined
as smoking 20 cigarettes daily for one year, and the
number of pack years each individual had smoked
was calculated on the basis of the information
provided by current or former smokers. Information
on duration of smoking, age when starting smoking,
and time since cessation of smoking was collected
from the questionnaire, and the response to each
variable was divided into tertiles for the statistical
analyses.
Brachial blood pressure was recorded in the sitting
position with the cuff placed on the right upper arm.
The registered systolic and diastolic blood pressures
were based on the mean value of the second and third
out of three consecutive measurements. For statistical
analyses both systolic and diastolic brachial blood
pressure were treated as ordinal variables.Statistical analyses
Logistic regression analysis was used to examine the
association between serum lipids, BMI, body shape,
and the prevalence of IC.19 Age was included in 5-year
categories to produce age-adjusted prevalence odds
ratios (OR) with 95% confidence intervals (95% CI). All
analyses were performed separately for men and
women, and P values were computed to assess trend
across categories (tertiles) by treating each exposure
variable as a continuous variable in the regression
model. In subsequent multivariate analyses we
assessed the effect of potentially confounding vari-
ables such as smoking habits, diabetes and diastolic or
systolic brachial blood pressure, by comparing age-
adjusted and multivariable adjusted estimates. All
statistical analyses were performed using the statisti-
cal software SPSS for Windows (Release 11.07, Copy-
right SPSS Inc., 1989–2003).Results
The prevalence of IC was similar for men (1.1%) and
women (1.2%), and IC subjects were approximately 6
years older than individuals without IC (Table 1). TheEur J Vasc Endovasc Surg Vol 30, 12 2005
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65 years or older (3.0% for men and 3.1% for women)
compared to those under the age of 45 (0.4% for men
and 0.3% for women). We observed no gender
differences for any of the 5 years age groups.16
For women, total cholesterol was not associated
with the prevalence of IC (P trendZ.461, Table 2).
However, for men there was a weak positive
association (P trendZ.055) between total cholesterol
and the prevalence of IC. Moreover, in men with total
serum cholesterol 6.6 mmol/L or higher the preva-
lence of IC was 60% higher (ORZ1.6; 95% CIZ1.0–2.6)
than men whose total cholesterol was lower than
5.5 mmol/L.
HDL cholesterol was strongly and negatively
associated with the prevalence of IC in women (P
trend!.001, Table 2) but not in men (P trendZ0.131).
The OR for women in the highest (R1.7 mmol/L)
compared with the lowest tertile (!1.3 mmol/L) of
HDL cholesterol was 0.3 (95% CIZ0.2–0.5). Compar-
ing women in the highest and lowest tertile of TC/
HDL cholesterol, the OR was 2.8 (95% CIZ1.6–4.7; P
trend!.001, Table 2). Among men, there was a
positive trend in prevalence related to tertiles of TC/
HDL cholesterol (OR of 1.7; 95% CIZ1.1–2.8; P trendZ
0.023).
There was a positive association between serum
concentrations of triglycerides and the prevalence of
IC in both genders (Table 2). In women, the association
displayed a strong trend across tertiles (P trendZ.002).
Women in the highest triglyceride category
(R1.40 mmol/L) were more than twice (ORZ2.2;
95% CIZ1.3–3.8) as likely to have IC compared to
women in the lowest tertile (!1.10 mmol/L). For men,
the strength of the association was weaker (P trendZ
.029) than for women, and the OR comparing theTable 1. Baseline characteristics of the cross sectional data stratified
Women
Cases
nZ122
N
n
Age 58.6G8.1 5
Total cholesterol level (mmol/L) 6.64G1.31 6
HDL-Cholesterol level (mmol/L) 1.43G0.42 1
Triglycerides (mmol/L) 2.12G1.21 1
Height (m) 1.64G0.06 1
Weight (kg) 71.5G12.5 7
Body mass index (kg/m2) 26.5G4.4 2
Waist circumference (cm) 85.9G11.1 8
Hip circumference (cm) 105.4G9.2 1
Waist to hip ratio 0.81G0.06 0
Never smokers (n) 39 4
Former smokers (n) 33 2
Current smokers (n) 50 3
Values are given as meanGstandard deviation.
Eur J Vasc Endovasc Surg Vol 30, 12 2005highest with the lowest category of serum levels of
triglycerides was 1.6 (95% CIZ1.0–2.6).
Women with body mass index (BMI) in the highest
tertile (R27.7) were more likely to have IC compared
to women whose BMI was in the lowest tertile (!24.2)
(ORZ1.7; 95% CIZ1.0–2.7, P trendZ.032), but in men,
we observed no such association (P trendZ.658,
Table 3). Women in the highest tertile of waist
(R86 cm) (ORZ1.7; 95% CIZ1.1–2.8, P trendZ.021)
and hip circumference (R105 cm) (ORZ1.7; 95% CIZ
1.1–2.6, P trendZ.020) were more likely to have IC
compared with women in the lowest tertile (Table 3).
In men, however, the measurements of waist (P
trendZ.392) and hip circumference (P trendZ.921)
were not related to the prevalence of IC. We observed
no association with IC for the ratio between waist and
hip circumference (body shape) in either gender.
In supplementary analyses, we assessed whether
any of these associations could be due to confounding
by current or previous smoking, number of cigarettes
smoked, time since smoking cessation, duration of
smoking, and number of pack years. Adjustment for
these factors, however, did not substantially influence
any of the results. Additional adjustments were made
for systolic and diastolic blood pressure, BMI, blood
levels of HbA1c, blood glucose levels, and previously
diagnosed diabetes mellitus, but the estimates
remained nearly identical.Discussion
We found a strong positive association between serum
concentrations of TC/HDL cholesterol and triglycer-
ides and the prevalence of intermittent claudication.
We observed a negative association between HDLby gender
Men
on-cases
Z10,122
Cases
nZ108
Non-cases
nZ9297
2.6G8.5 59.1G8.3 52.9G8.5
.12G1.22 6.35G1.32 6.06G1.13
.55G0.40 1.24G0.51 1.34G0.42
.68G1.02 2.46G1.83 2.15G1.29
.63G0.07 1.77G0.06 1.75G0.06
4.1G13.3 84.6G11.9 83.9G12.6
8.0G5.0 26.9G3.4 27.2G3.8
2.2G11.1 94.9G10.4 93.0G8.8
02.8G9.0 102.5G6.2 102.7G5.9
.79G0.06 0.92G0.07 0.89G0.06
722 19 3577
229 35 3014
270 54 2706
Table 2. Age-adjusted odds ratio (OR) and 95% confidence interval (CI) for the prevalence of IC associated with blood lipid
measurements
Variables Women Men
Cases Non-
cases
OR 95% CI P trend* Cases Non-
cases
OR 95% CI P trend*
Total cholesterol (mmol/L)†
T1 31 3410 1.0 Reference 27 3130 1.0 Reference
T2 26 3340 0.6 (0.4–1.0) 34 3052 1.2 (0.7–2.0)
T3 64 3462 1.1 (0.7–1.7) .461 47 3102 1.6 (1.0–2.6) .055
HDL cholesterol (mmol/L)‡
T1 67 3502 1.0 Reference 40 2702 1.0 Reference
T2 32 3124 0.6 (0.4–0.9) 33 3420 0.6 (0.4–1.0)
T3 22 3586 0.3 (0.2–0.5) !.001 35 3159 0.7 (0.5–1.1) .131
Total-/HDL-cholesterol§
T1 18 3433 1.0 Reference 27 3116 1.0 Reference
T2 33 3409 1.5 (0.8–2.7) 34 3078 1.3 (0.8–2.1)
T3 70 3370 2.8 (1.6–4.7) !.001 47 3087 1.7 (1.1–2.8) .023
Triglycerides (mmol/L)¶
T1 19 3411 1.0 Reference 30 3113 1.0 Reference
T2 40 3423 1.6 (0.9–2.8) 30 3087 1.0 (0.6–1.6)
T3 62 3378 2.2 (1.3–3.8) .002 48 3084 1.6 (1.0–2.6) .029
* P values for test of trend by logistic regression model when variables as ordinal variables.
† Cut points for tertiles of total cholesterol were 5.6 and 6.6 for men, and 5.5 and 6.5 for women.
‡ Cut points for tertiles of HDL-cholesterol were 1.1 and 1.4 for men, and 1.3 and 1.7 for women.
§ Cut points for tertiles of the ratio of total cholesterol to HDL-cholesterol were 3.5 and 4.6 for men, and 4.3 and 5.6 for women.
¶ Cut points for tertiles of triglycerides were 1.1 and 1.7 for men, and 1.1 and 1.4 for women.
Serum Lipids, Anthropometric Factors, Claudication 585cholesterol and the prevalence of intermittent claudi-
cation, especially in women. In agreement with our
findings, most previous studies have shown positive
associations between TC/HDL cholesterol, triglycer-
ides, and IC. However, for total serum cholesterol and
HDL cholesterol results have varied between studies
and no consistent pattern has emerged.8,18,20–23 Most
previous population surveys addressing lower limbTable 3. Age-adjusted odds ratio (OR) and 95% confidence interval (CI
to hip-ratio
Variables Women
Cases Non-
cases
OR 95% CI P tren
BMI (kg/m2)†
T1 26 3416 1.0 Reference
T2 38 3403 1.2 (0.8–2.1)
T3 57 3380 1.7 (1.0–2.7) .032
Waist (cm)‡
T1 26 3465 1.0 Reference
T2 36 3321 1.2 (0.7–2.0)
T3 60 3408 1.7 (1.1–2.8) .021
Hip (cm)§
T1 29 3459 1.0 Reference
T2 35 3410 1.1 (0.7–1.8)
T3 58 3326 1.7 (1.1–2.6) .020
Waist/hip-ratio¶
T1 26 3391 1.0 Reference
T2 47 3380 1.6 (1.0–2.6)
T3 49 3423 1.4 (0.9–2.4) .179
* P values for test of trend by logistic regression model when variab
† Cut points for tertiles of BMI were 25.3 and 27.9 for men, and 24.2
‡ Cut points for tertiles of waist circumference were 89.1 and 96.2 fo
§ Cut points for tertiles of hip circumference were 100.1 and 105.2 fo
¶ Cut points for tertiles of the ratio of waist to hip circumference wearterial disease were designed to study coronary heart
disease, few studies included a large number of
women, and very few have investigated an unselected
population with a large number of male and female
smokers.
We have tested the validity of the questions by
adding the ankle brachial pressure index !0.9 as a
gold standard of peripheral occlusive disease in a) for the prevalence of IC associated with BMI, waist, hip and waist
Men
d* Cases Non-
cases
OR 95% CI P trend*
32 3094 1.0 Reference
38 3099 1.2 (0.7–1.9)
37 3090 1.1 (0.7–1.8) .658
33 3265 1.0 Reference
28 2801 0.9 (0.5–1.5)
47 3214 1.2 (0.8–1.9) .392
39 3424 1.0 Reference
34 2624 1.2 (0.7–1.8)
35 3232 1.0 (0.6–1.5) .921
27 3125 1.0 Reference
29 3085 1.0 (0.6–1.6)
52 3070 1.5 (0.9–2.4) .076
les as ordinal variables.
and 27.7 for women.
r men, and 76.3 and 86.0 for women.
r men, and 98.0 and 105.2 for women.
re 0.88 and 0.92 for men, and 0.77 and 0.82 for women.
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only about 20% of those with ABPI !0.9 were likely to
be detected by our questions (sensitivity of 19.2%).15,16
Symptoms of IC may be interchangeable with other
diseases, and such misclassification is likely even in
symptomatic subjects. We estimated the positive
predictive value of our IC questionnaire to be 45.5%
compared to the gold standard of ABPI!0.9.15,16 Thus,
our questionnaire had test properties similar to those
of the WHO/Rose questionnaire and the Edinburgh
claudication questionnaire.12–14
In the analysis of each lipid we did not simul-
taneously adjust for other lipids, because of their close
biological relation, which may result in statistical co-
linearity. In supplementary analyses, however, we
explored whether the results related to serum lipids
could be confounded by different smoking habits,
diabetes, body mass, and systolic or diastolic blood
pressure. Adjustment for these factors, however, did
not substantially change the results.
The prevalence of previously diagnosed diabetes in
this population was 2.8% for men and 2.1% for
women. Diabetes mellitus is associated with hyper-
triglyceridemia, thus low levels of HDL cholesterol,
and consequently progression of lower limb arterial
disease.7 Adjustment for the presence of diabetes,
blood levels of glucose or HbA1c did not substantially
influence any of the results. The association between
hypertriglyceridemia, low serum concentrations of
HDL cholesterol, and IC are, therefore, not influenced
by diabetes, and thus these factors must be considered
independent risk factors for IC even in otherwise
healthy subjects.
Statins protect against coronary events and stroke,
and recent clinical trials comparing standard regimens
with more intensive statin therapy have shown that
the latter reduces the risk of disease even further.25,26
Thus, lipid lowering treatment for indigent coronary
and stroke patients appears to be an area of high
priority. In relation to patients with IC but without
coronary heart disease, however, lipid lowering
treatment has not yet become a standard regimen.27
Nevertheless, findings now indicate that most patients
with a high risk of vascular events could benefit from
such treatment.28–31 Our results suggest that serum
levels of TC/HDL cholesterol and triglycerides are
positively associated with IC both for men and
women, and thus, the results may support lipid
lowering treatment for IC patients.
Obese people have a relatively high serum concen-
tration of TC/HDL cholesterol and triglycerides, and
are thus at increased risk of hypertension, diabetes,
and cardiovascular events.32,33 Further, TC/HDL
cholesterol is the best predictor both for outcome andEur J Vasc Endovasc Surg Vol 30, 12 2005treatment benefit in obese people.18 Weight reduction
lowers plasma lipids, and may therefore slow down
the development of vascular occlusive diseases.34 Both
large waist circumference and high waist-to-hip ratio
(‘apple-shape’) are suggested to predispose to coron-
ary heart disease.35,36 In women, we found high BMI to
be associated with higher prevalence of IC, but there
was no clear association between body shape and the
prevalence of IC in either women or men.
It has been hypothesized that elevated levels of
estrogens may reduce the risk of peripheral arterial
disease in women by lowering TC/HDL and increas-
ing HDL cholesterol.37 However, there is little
evidence in the literature for such associations.37 We
observed no gender differences for the association
between IC, TC/HDL and HDL cholesterol, and our
findings therefore support previous reports
suggesting that there is no association between
endogenous sex hormones and the development of
peripheral arterial disease.
In summary, TC/HDL cholesterol and triglycerides
were positively, and HDL cholesterol was negatively
associated with the prevalence of intermittent claudi-
cation both in men and women, but the associations
were generally stronger for women than for men. High
BMI and wide waist and hip circumference were
positively associated with the prevalence of IC in
women, but not in men.References
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